Citation Impact
Citing Papers
Impact of hydroxyurea on clinical events in the BABY HUG trial
2012
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Use of red blood cell exchange for treating acute complications of sickle cell disease
2018
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Pulmonary hypertension in well-transfused thalassemia major patients
2014
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
2016
Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults
2009
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Oral Anticoagulant Therapy
2012 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
A global view of pulmonary hypertension
2016 Standout
Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea
2008
Haematopoietic cell transplantation in the treatment of sickle cell disease
2003
Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature
2011
Conversion of biomass to selected chemical products
2011 Standout
Clinical management of adult sickle-cell disease
2012
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome
2016
Delivery technologies for cancer immunotherapy
2019 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
2020 Standout
Outcome of Sickle Cell Anemia
2005
T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders
2007
Advances in clinical research in sickle cell disease
2008
Infections, Antigen-Presenting Cells, T Cells, and Immune Tolerance: Their Role in the Pathogenesis of Immune Thrombocytopenia
2009
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
2012
Vincristine: Can its therapeutic index be enhanced?
2009
Platelets and the immune continuum
2011 Standout
Pediatric Idiopathic Intracranial Hypertension
2007
Sickle-cell disease
2010 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Chronic Eosinophilic Leukemias and the Myeloproliferative Variant of the Hypereosinophilic Syndrome
2007
The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up
2010
Increased leukemia-associated gene expression in benzene-exposed workers
2014
An update on the management of severe idiopathic aplastic anaemia in children
2007
Indications and complications of transfusions in sickle cell disease
2012
Pediatric Idiopathic Intracranial Hypertension
2007
Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children
2008
Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia
2015
ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature
2001
Red Cell Exchange in Sickle Cell Disease
2006
Five years since the discovery of FIP1L1–PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
2008
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis
2013
IgE, mast cells, basophils, and eosinophils
2010 Standout
Prevalence of pulmonary hypertension in hereditary spherocytosis
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial
2015
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study
2018
G-CSF and GM-CSF in Neutropenia
2015
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy
2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease
2014
Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease
2016
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Epidemiologic study of major complications in adolescent and adult patients with thalassemia in Northeastern Thailand: the E-SAAN study phase I
2017
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor
2013
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Nanomedicine(s) under the Microscope
2011
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
2013 Standout
How I treat hemophagocytic lymphohistiocytosis
2011
Potential Health Effects Associated with Dermal Exposure to Occupational Chemicals
2014 Standout
Characterization of the Fetal Blood Transcriptome and Proteome in Maternal Anti‐Fetal Rejection: Evidence of a Distinct and Novel Type of Human Fetal Systemic Inflammatory Response
2013
Transfusion therapy for sickle cell disease: a balancing act
2013
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
How I manage cerebral vasculopathy in children with sickle cell disease
2015
Preterm labor: One syndrome, many causes
2014 StandoutScience
The catalytic oxidation of biomass to new materials focusing on starch, cellulose and lignin
2010
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response
2008
Hematological Problems in Pediatric Intensive Care
2013 Standout
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
2005
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Michael Jeng being referenced
Chronic Transfusion Therapy for Children With Sickle Cell Disease and Recurrent Acute Chest Syndrome
2005
Resolution of Chronic Hepatic Sequestration in a Patient With Homozygous Sickle Cell Disease Receiving Hydroxyurea
2003
Natural history of moderate aplastic anemia in children
2004
Adherence to study medication and visits: Data from the BABY HUG trial
2009
Epstein–Barr virus‐associated peripheral T‐cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature
2004
Gene expression profile of idiopathic thrombocytopenic purpura (ITP)
2006
Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia versus sickle‐cell disease
2006
Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease
2010
Precursor B‐cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis
2006
Pseudotumor Cerebri in Two Adolescents with Acquired Aplastic Anemia
2002
Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies
2009
Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy
2014
Phase Ib clinical trial of starch‐conjugated deferoxamine (40SD02): a novel long‐acting iron chelator
2007
Cold agglutinin syndrome in pediatric liver transplant recipients
2007
Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia
2005
Summary of Symposium: The Future of Stem Cell Transplantation for Sickle Cell Disease
2002
ITRACONAZOLE-ENHANCED VINCRISTINE NEUROTOXICITY IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2001
Central venous catheter complications in sickle cell disease
2002
Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia.
2005
Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
2004
#455 Severe vincristine toxicity potentiated by itraconazole therapy in a child with acute lymphoblastic leukemia
1999
Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells
2000
Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells
2000
The Platelet-Derived Growth Factor Receptor beta Fuses to Two Distinct Loci at 3p21 in Imatinib Responsive Chronic Eosinophilic Leukemia.
2005
Identification of Specific Chemokines and Apoptosis Molecules in Pediatric Idiopathic Neutropenia.
2006
The Effect of Thalassemia and Other RBC Hemolytic Disorders and Splenectomy on the Frequency of Pulmonary Hypertension
2010